Our results and those of Thomas and colleagues indicate that early targeting with an HDAC3-selective inhibitor significantly prevents or delays cognitive deficits, somatic CAG repeat expansions and motor dysfunction in HD mice. The gene discussed is HDAC3; the disease is Huntington disease.